Labcorp Drug Development: Medidata Sensor Cloud agreement

Medidata, a Dassault Systèmes company, has announced a partnership with Labcorp Drug Development. Under the terms, Medidata will receive and process medical-grade sensor data within drug, vaccine and device trials across Labcorp Drug Development’s clinical trial portfolio, specifically enhancing their decentralized clinical trial offerings.

“Sensor Cloud solves key technical, operational, and analytical challenges that have historically stifled the widespread usage of medical devices in clinical research​,” said Ben Schlatka, vice president of digital biomarker solutions at Medidata. “Combining the power of Sensor Cloud with Labcorp’s innovative approach to clinical research and its scale in clinical diagnostics will transform how patient data are collected, managed, analyzed and leveraged—driving faster, more effective drug development and overall better health outcomes​.”